CX 31- Dr Becquemin chairs session on thoracic aorta interventions


The post-lunch session on Monday, 6 April, will see the spotlight turn to talks and presentations concerning the thoracic aorta.
The session opens with Marty Leon from Washington DC, USA, scheduled to talk on percutaneous heart valve deployment. Then, Dr Michael Dake from Stanford, California, USA, and Dr Peter Taylor from London, UK, debate the topic, “Fit patients with uncomplicated aortic dissection with dilated aorta should have TEVAR.”

For the dormer, good results for the safety and effectiveness of the endovascular procedure hold the key to the question. He says, “The answer hinges on the successful demonstration of the safety and effectiveness of the endovascular procedure.” On the other hand, Taylor bases his argument on the fact that it is important not to treat conditions using endovascular therapy just because it is technically possible. Then, Dr Ron Fairman from Philadelphia, USA, presents on the specific complication of retrograde type A dissection following TEVAR.

After this, Christoph Nienaber from Rostock, Germany, reviews current indication, timing, and results of endovascular management of patients with type B aortic dissection in the context of recent literature. Also presenting on the day is Eric Walser of Jacksonville, Florida, USA, who talks on the topic “TEVAR does not require CT follow-up.”? Walser finds that thoracic aortic intervention differs from that in the abdominal aorta in terms of anatomy, procedural details and complications. So, he says, “Imaging follow-up should not necessarily mirror that of abdominal aortic aneurysm repair.”

Dr Manish Mehta of Albany, USA, who presents on the topic, Endovascular vs. open repair of ruptures thoracic aortic aneurysms,says, “The findings of our study indicate that endovascular repair of ruptured thoracic aortic aneurysms has a significant impact on decreasing operative mortality and this survival advantage is also noted at one year, when compared to open surgical repair. Also, the endovascular therapy for these high-risk patients might increase our ability to treat patients with these thoracic aortic emergencies that might have otherwise been left untreated.

Dr Matt Thomson, London, UK, proposes that the diameter criteria for TEVAR need to be reset. He finds that with the advent of endovascular aortic repair, there has been considerable discussion regarding the threshold diameters that trigger intervention.

Also, Dr Mario Lachat from Zurich, Switzerland, reports on experiences in 20 cases where Viabahn debranching was performed through a sternotomy.
Lachat shares emerging results from the introduction of a new nonsutured, Viabahn-based revascularisation technique of the supra-aortic vessels.

Register now on
Download the special CX 31issue of Vascular News by clicking on the icon to the right.